Or Wes and the board are only going to do buybacks when they believe the share price it is significantly undervalued, I’d prefer they’d do organic or inorganic growth over share buybacks as this will deliver more long term growth for shareholders if they get it right. I see this stock as a good outperformer over the long term though with Wes’ track record of building this business
- Forums
- ASX - By Stock
- MGH
- Ann: Investor Presentation May 2023
Ann: Investor Presentation May 2023, page-14
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MGH (ASX) to my watchlist
|
|||||
Last
$4.10 |
Change
-0.070(1.68%) |
Mkt cap ! $1.367B |
Open | High | Low | Value | Volume |
$4.16 | $4.16 | $4.10 | $51.50K | 12.51K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 780 | $4.09 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.10 | 132 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 779 | 4.090 |
4 | 1982 | 4.080 |
2 | 860 | 4.070 |
4 | 3930 | 4.060 |
4 | 19684 | 4.050 |
Price($) | Vol. | No. |
---|---|---|
4.100 | 132 | 3 |
4.110 | 1826 | 5 |
4.120 | 1798 | 4 |
4.130 | 1344 | 3 |
4.140 | 1113 | 5 |
Last trade - 11.59am 13/08/2024 (20 minute delay) ? |
Featured News
MGH (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online